IntrinsicIntrinsic
OverviewFinancialsChartBusiness SummaryFilingsOwnershipValuation

Financial Statements — XENE

Balance Sheet

(in billions USD)
MetricQ2 2026Q1 2026Q3 2025Q2 2025Q1 2025Q3 2024Q2 2024Q1 2024Q3 2023Q2 2023Q1 2023Q3 2022Q2 2022Q1 2022Q3 2021Q2 2021Q1 2021
Cash & Equivalents0.120.550.100.140.120.090.140.060.100.060.070.100.370.120.090.080.09
Short-term Investments0.810.550.360.350.430.570.580.640.430.480.460.530.420.420.160.180.19
Accounts Receivable----------0.000.000.000.000.000.000.000.000.000.000.000.01
Total Current Assets0.951.110.480.500.570.660.730.710.530.540.530.650.790.550.260.270.28
Property, Plant & Equipment0.010.010.010.010.010.010.010.010.010.010.010.000.000.000.000.000.00
Total Non-current Assets*0.350.280.130.170.180.180.160.210.140.140.190.130.010.010.010.010.01
Total Assets1.301.390.610.670.740.840.880.920.670.680.720.780.810.560.260.270.29
Accounts Payable0.040.040.040.030.030.030.030.020.020.030.020.020.010.010.010.010.01
Total Current Liabilities0.050.040.040.030.030.030.030.020.020.030.020.020.010.010.010.010.01
Total Non-current Liabilities*0.010.010.010.010.010.010.010.010.010.010.010.010.010.010.000.000.00
Total Liabilities0.050.050.050.040.040.040.040.030.030.040.030.020.020.020.020.020.01
Retained Earnings(1.46)(1.35)(1.14)(1.05)(0.96)(0.83)(0.77)(0.71)(0.62)(0.57)(0.52)(0.45)(0.41)(0.38)(0.33)(0.32)(0.29)
Total Stockholder Equity1.241.340.560.630.700.800.840.890.640.650.690.750.790.540.250.260.28

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Total Revenue0.000.000.000.000.007.500.000.00----------8.770.000.130.548.773.748.12
Research & Development99.2288.5187.7077.0574.9961.2059.4756.9749.7044.2541.0842.8844.0439.5234.8329.4322.1519.3621.8918.89
Selling, General & Admin23.9323.8222.0719.2819.2419.0418.0116.7119.4014.7912.6212.8011.589.548.508.838.716.786.694.83
Total Operating Expenses123.16112.33109.7796.3494.2380.2477.4873.6869.1059.0453.7055.6855.6249.0543.3338.2630.8526.1428.5823.72
Operating Income(123.15)(112.33)(109.77)(96.34)(94.23)(72.74)(77.48)(73.68)(69.10)(59.04)(53.69)(55.68)(55.62)(49.05)(43.33)(38.13)(30.31)(17.37)(24.84)(15.60)
Pretax Income(111.32)(104.87)(104.72)(90.22)(85.33)(64.62)(69.53)(63.11)(58.26)(47.52)(44.95)(48.62)(47.68)(41.44)(36.26)(37.74)(31.20)(20.06)(25.08)(15.65)
Tax Provision(0.58)(2.57)0.540.68(0.63)0.43(3.85)(0.32)(0.33)0.41(0.20)(0.16)(0.22)0.291.14(0.59)(0.04)(0.39)0.48(0.20)
Net Income(110.74)(102.30)(105.26)(90.90)(84.71)(65.05)(65.68)(62.79)(57.92)(47.93)(44.74)(48.46)(47.46)(41.73)(37.40)(37.15)(31.16)(19.67)(25.56)(15.44)
Basic EPS(1.11)(1.17)(1.31)(1.15)(1.07)(0.83)(0.83)(0.81)(0.75)(0.62)(0.65)(0.73)(0.72)(0.63)(0.57)(0.57)(0.55)------
Diluted EPS(1.11)(1.17)(1.31)(1.15)(1.07)(0.83)(0.83)(0.81)(0.75)(0.62)(0.65)(0.73)(0.72)(0.63)(0.57)(0.57)(0.55)------

Cash Flow Statement

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Operating Cash Flow(95.39)(88.90)(81.48)(71.75)(64.23)(61.65)(54.38)(51.15)(32.68)(43.18)(35.47)(42.23)(33.22)(34.41)(32.73)(30.40)(16.87)(18.43)(20.71)(15.01)
Capital Expenditures0.280.130.320.280.160.040.780.591.510.190.081.202.132.211.750.390.540.210.510.22
Free Cash Flow*(95.66)(89.03)(81.80)(72.03)(64.39)(61.69)(55.17)(51.74)(34.19)(43.37)(35.54)(43.43)(35.35)(36.62)(34.48)(30.79)(17.41)(18.64)(21.22)(15.23)
Investing Cash Flow(331.24)(407.28)62.7038.5382.2634.5198.501.98110.72(46.20)(239.73)48.0327.9046.62(14.33)(234.10)1.32(48.89)(215.43)15.58
Financing Cash Flow0.03843.01113.542.360.071.15--------324.0129.51----0.010.70269.897.88323.954.76

* Derived from reported values